TradeLane

Why is it that chemicals and pharmaceutical items are often classified incorrectly? The answer has more to do with the nature of pharmaceutical trade than the complexity of the tariff (though it is complex). In an industry with its fair share of non-commercial product movements for testing, diagnosis, analysis, and new product development, that ‘newness’ and the speed at which product moves can make compliance determination challenging. However, meeting reasonable care standards makes attention to and investment in an accurate classification process critical. Here are some tips on how to get it right.

Understanding Dual-Use regulation, or regulation controlling the export of commodities with a civilian or military end-use, can be complicated. The development of these rules and regulations continues. Regulators are trying to keep up with the technical developments in the market, geopolitical developments globally, and their own economic interests. European regulators meet with traders within the European Union periodically at the European Union (EU) Export Control Forum to discuss the topic at hand and share best practices and developments. 

The Court of International Trade has ordered that the tariff actions imposed by the Office of the United States Trade Representative, as amended on remand by Further Explanation of the Final List 3 and Final List 4 Modifications Pursuant to Court Remand Order, ECF No. 467, are sustained.

In a nutshell, while the Court ordered the government to correct the record - ECF 466, Sec. 301 Final Lists 3 & Final 4a are valid and remain in place.

On January 27^th, Tradewin published our ‘Reconciliation Step by Step’ guide. For those interested, a copy is available for download below:

On 26 January 2023, the Philippine Strategic Trade Management Office (STMO) issued an announcement (Announcement No. 2023-001) to exporters emphasizing the need to properly classify their goods under the National Strategic Goods List (NSGL) prior to registration with the STMO.